Camilla Muccini

Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

Marco Ripa, Laura Galli, Andrea Poli et al. · Clinical Microbiology and Infection · 2020 · 383 citations · Full text

Infectious Disease Epidemiology, Predictive Factors, Healthcare-associated Infection +12

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium

Bastian Neesgaard, Lauren Greenberg, José M. Miró et al. · The Lancet HIV · 2022 · 126 citations · Full text

Cardiovascular Epidemiology, Cardiovascular Disease, Treatment And Prevention +8

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

Loveleen Bansi‐Matharu, Andrew Phillips, Cristiana Oprea et al. · The Lancet HIV · 2021 · 59 citations · Full text

Sexual Health, Epidemiological Trend, Preventive Medicine +13

Analytical treatment interruption in chronic HIV-1 infection: time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study)

Antonella Castagna, Camilla Muccini, Laura Galli et al. · Journal of Antimicrobial Chemotherapy · 2019 · 40 citations

Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients

Nadia Galizzi, Andrea Poli, Laura Galli et al. · International Journal of Antimicrobial Agents · 2020 · 34 citations

Retrospective Study, Reverse Transcriptase Inhibitor, Human Retrovirus +8